• 1
    Allen TA, Jaenke RS, Fetteman MJ. A technique for estimating progression of chronic renal failure in the dog. J Am Vet Med Assoc 1987; 190:866868.
  • 2
    Brown SA. Primary diseases of glomeruli. In: OsborneCA, Fin-coDR, eds. Canine and Feline Nephrology/Urology. Philadelphia , PA : Williams and Wilkins; 1995: 368385.
  • 3
    Finco DR, Brown CA. Primary tubulo-interstitial diseases of the kidney. In: OsborneCA, FincoDR, eds. Canine and Feline Nephrology/Urology. Philadelphia , PA : Williams and Wilkins; 1995: 386391.
  • 4
    Hostetter TH, Olson JH, Rennke HG, et al. Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. Am J Physiol 1981;241:F85F93.
  • 5
    Finco DR. Kidney function. In: KanekoJJ, HarveyJW, BrussML, eds. Clinical Biochemistry of Domestic Animals. New York , NY : Academic Press; 1997: 441484.
  • 6
    Gaspari F, Perico N, Remuzzi G. Measurement of glomerular filtration rate. Kidney Int 1997;63(Suppl):S151S154.
  • 7
    Osborne CA, Low DG. Iatrogenic lesions in serial renal biopsy samples. J Urol 1971;106:805810.
  • 8
    Klahr S, Levey AS, Beck GJ, et al. The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. N Engl J Med 1994;330:877884.
  • 9
    Locatelli F, Manzoni C, Marcelli D. Factors affecting progression of renal insufficiency. Miner Electrolyte Metab 1997;23:301305.
  • 10
    Anderson S, Brenner B. Progressive renal disease: A disorder of adaptation. QJM 1989;263:185189.
  • 11
    Schwartz MM, Bidani AK. Role of glomerular epithelial cell injury in the pathogenesis of glomerular scarring in the rat remnant kidney model. Am J Pathol 1993; 142:209219.
  • 12
    Johnson RJ. What mediates progressive glomerulosclerosis? The glomerular endothelium comes of age. Am J Pathol 1997; 151: 11791181.
  • 13
    Lee LK, Meyer TW, Pollack AS, et al. Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney. J Clin Invest 1995;96:953964.
  • 14
    Cortes P, Riser B, Narins RG. Glomerular hypertension and progressive renal disease: The interplay of mesangial cell stretch, cytokine formation and extracellular matrix synthesis. Contrib Nephrol 1996; 118:229233.
  • 15
    Schwartz MM, Evans J, Bidani AK. The mesangium in the long-term remnant kidney model. J Lab Clin Med 1994; 124:644651.
  • 16
    Smith HW The Kidney: Structure and Function on Health and Disease. New York , NY : Oxford University Press; 1951: 476481.
  • 17
    Fogo A, Hawkins EP, Berry EP, et al. Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis. Kidney Int 1990;38:115123.
  • 18
    Lee HS, Lim SD. The significance of glomerular hypertrophy in focal segmental glomerulosclerosis. Clin Nephrol 1995;44:349355.
  • 19
    Lafferty HM, Brenner BM. Are glomerular hypertension and “hypertrophy” independent risk factors for progression of renal disease Semin Nephrol 1990;10:294304.
  • 20
    Zatz R, Fujihara CK. Glomerular hypertrophy and progressive glomerulopathy. Is there a definite pathogenic connection? Kidney Int 1994;45(Suppl):S27S29.
  • 21
    Tenschert S, Elger M, Lemly KV. Glomerular hypertrophy after subtotal nephrectomy: Relationship to early glomerular injury. Vir-chows Arch 1995;426:509517.
  • 22
    Miller PL, Rennke HG, Meyer TW. Glomerular hypertrophy accelerates hypertensive glomerular injury in rats. Am J Physiol 1991; 261:F459F465.
  • 23
    Hostetter TH. Progression of renal disease and renal hypertrophy. Annu Rev Physiol 1995;57:263278.
  • 24
    Nath KA. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 1992;20:117.
  • 25
    Nath KA. The tubulointerstitium in progressive renal disease. Kidney Int 1998;54:992994.
  • 26
    Yee J, Kuncio GS, Neilson EG. Tubulointerstitial injury following glomerulonephritis. Semin Nephrol 1991;11:361366.
  • 27
    Cameron JS. Tubular and interstitial factors in the progression of glomerulonephritis. Pediatr Nephrol 1992;6:292303.
  • 28
    Jones CL, Allison AE. Tubulointerstitial nephritis. Pediatr Nephrol 1992;6:572586.
  • 29
    Strutz F, Muller GA. On the progression of chronic renal disease. Semin Renal Physiol 1995;69:371379.
  • 30
    Bohle A, Muller GA, Wehrmann M, et al. Pathogenesis of chronic renal failure in primary glomerulopathies, renal vasculopa-thies, and chronic interstitial nephritides. Kidney Int 1996; 54 (Suppl): S2S9.
  • 31
    Palmer B. The renal tubule in the progression of chronic renal failure. J Invest Med 1997;45:346361.
  • 32
    El-Nahas AM, Paraskevakou H, Zoob S, et al. Effects of dietary protein restriction on the development of renal failure after subtotal nephrectomy in rats. Clin Sci 1983;65:399406.
  • 33
    Anderson S, Rennke HG, Brenner BM. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with arterial hypertension. J Clin Invest 1986;77:19932000.
  • 34
    Burton C, Harris KP The role of proteinuria in the progression of chronic renal failure. Am J Kidney Dis 1996;27:765775.
  • 35
    Herrera GA. Low molecular weight proteins and the kidney: Physiologic and pathologic considerations. Ultrastruct Pathol 1994; 18: 8998.
  • 36
    Hirschberg R. Bioactivity of glomerular ultrafiltrate during heavy proteinuria may contribute to renal tubulo-interstitial lesions. J Clin Invest 1996;98:116124.
  • 37
    Benagni A, Zoja C, Remuzzi G. The renal toxicity of sustained glomerular protein traffic. Lab Invest 1995;73:461468.
  • 38
    Jerums G, Panagiotopouolos S, Tsalamandris C, et al. Why is proteinuria such an important risk factor for progression in clinical trials Kidney Int 1998;63(Suppl):S87S92.
  • 39
    Kees FD, Sadow JL, Schreiner GE Tubular catabolism of albumin is associated with the release of an inflammatory liquid. Kidney Int 1994;45:16971709.
  • 40
    Stratta P, Canavese C, Dogliani M, et al. The role of free radicals in the progression of renal disease. Am J Kidney Dis 1991; 17(Suppl 1):S33S37.
  • 41
    Nath KA, Salahudeen AK. Induction of renal growth and injury in intact rat kidney by dietary deficiency of antioxidants. J Clin Invest 1990;86:11791192.
  • 42
    Nath KA, Grande J, Croatt A, et al. Redox regulation of renal DNA synthesis, transforming growth factor-beta-1, and collagen gene expression. Kidney Int 1998;53:367381.
  • 43
    Hahn S, Kuemmerle NB, Chan W, et al. Glomerulosclerosis in the remnant kidney rat is modulated by dietary alpha-tocopherol. J Am Soc Nephrol 1998;9:20892095.
  • 44
    Klahr S. Oxygen radicals and renal diseases. Miner Electrolyte Metab 1997;23:140143.
  • 45
    Nath KA, Hostetter MK, Hostetter TH. Increased ammoniagen-esis as a determinant of progressive renal injury. Am J Dis Kidney 1991;17:654657.
  • 46
    Throssell D, Brown J, Harris KP, et al. Metabolic acidosis does not contribute to chronic renal injury in the rat. Clin Sci 1995;89:643650.
  • 47
    Bailey J. Metabolic acidosis and protein catabolism: Mechanisms and clinical implications. Miner Electrolyte Metab 1998;24:1319.
  • 48
    Bailey J, Wang X, England BK, et al. The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway. J Clin Invest 1996;97:14471453.
  • 49
    Bailey JL, Mitch WE. Metabolic acidosis as a uremic toxin. Semin Nephrol 1996;16:160166.
  • 50
    Motojima M, Nishijima F, Ikoma M, et al. Role for “uremic toxin” in the progressive loss of intact nephrons in chronic renal failure. Kidney Int 1991;40:461469.
  • 51
    Yu PH, Dyck RE Impairment of methylamine clearance in uremic patients and its nephropathological implications. Clin Nephrol 1998;49:299302.
  • 52
    Ringoir S. An update on uremic toxins. Kidney Int 1997;62 (Suppl):S2S4.
  • 53
    Ringoir S, Vanholder R, Massry S. Advances in Experimental Medicine and Biology: Uremic Toxins, Vol 223. New York , NY : Plenum Press; 1986.
  • 54
    Benigni A, Zoja C, Corna D, et al. Blocking both type A and B endothelin receptors in the kidney attenuates renal injury and prolongs survival in rats with remnant kidney. Am J Kidney Dis 1996; 27:416423.
  • 55
    Silbiger S, Neugarten J. The impact of gender on the progression of chronic renal disease. Am J Kidney Dis 1995;25:515533.
  • 56
    Gafter U, Ben-Bassat M, Levi J. Castration inhibits glomerular hypertrophy and proteinuria in uninephrectomized male rats. Eur J Clin Invest 1990;20:360365.
  • 57
    Ciombra TM, Carvalho J, Fattori A, et al. Transforming growth factor-β production during the development of renal fibrosis in rats with subtotal nephrectomy. Int J Exp Pathol 1996;77:167173.
  • 58
    Ketteler M, Noble NA, Border WA. Transforming growth factor-β and angiotensin II: The missing link from glomerular hyperfil-tration to glomerulosclerosis. Annu Rev Physiol 1995;57:279295.
  • 59
    Harris RC, Martinez-Maldonado M. Angiotensin II-mediated renal injury. Miner Electrolyte Metab 1995;21:13281333.
  • 60
    Frishberg Y, Kelly CJ. TGF-β and regulation of interstitial nephritis. Miner Electrolyte Metab 1998;24:181189.
  • 61
    Shankland SJ, Johnson RJ. TGF-β and glomerular disease. Miner Electrolyte Metab 1998;24:168173.
  • 62
    Finco DR, Brown SA, Crowell WA, et al. Exogenous creatinine clearance as a measure of glomerular filtration rate in dogs with reduced renal mass. Am J Vet Res 1991;52:10291032.
  • 63
    Finco DR, Tabaru H, Brown SA, et al. Endogenous creatinine clearance measurement of glomerular filtration rate in dogs. Am J Vet Res 1993;54:15751578.
  • 64
    Finco DR, Brown SA, Vaden S, et al. Relationship between plasma creatinine concentrations and glomerular filtration in dogs. J Vet Pharmacol Ther 1995;18:418421.
  • 65
    Freenby B. Use of iohexol to determine glomerular filtration rate. A comparison between different clearance techniques in man and animals. Scand J Urol Nephrol 1997; 182(Suppl):163.
  • 66
    Moe L, Heiene R. Estimation of glomerular filtration rate in dogs with 99M-Tc-DTPA and iohexol. Res Vet Sci 1995;58:138143.
  • 67
    Brown SA, Finco DR, Boudinot D, et al. Evaluation of a single injection method, using iohexol, for estimating glomerular filtration rate in cats and dogs. Am J Vet Res 1996;57:105110.
  • 68
    Gleadhill A, Michell AR. Evaluation of iohexol as a marker for clinical measurement of glomerular filtration rate in dogs. Res Vet Sci 1996;60:117121.
  • 69
    Cowgill LD, Hornof W J. Assessment of individual kidney function by quantitative renal scintigraphy. In: KirkRW, ed. Current Veterinary Therapy IX. Philadelphia , PA : WB Saunders; 1986: 11081110.
  • 70
    Kraweic DR, Badertscher RR, Twardock AR, et al. Evaluation of 99mTC-dethylene-triaminepentaacetic acid nuclear imaging for quantitative determination of the glomerular filtration rate of dogs. Am J Vet Res 1986;47:21752179.
  • 71
    Brown SA, Finco DR, Crowell WA, et al. Single nephron adaptations to partial renal ablation on the dog. Am J Physiol 1990; 258: F495F503.
  • 72
    Brown SA, Finco DR, Crowell WA, et al. Dietary protein intake and the glomerular adaptations to partial nephrectomy in dogs. J Nutr 1991;121:S125S127.
  • 73
    Cowgill LD. Systemic hypertension. In: KirkRW, ed. Current Veterinary Therapy IX. Philadelphia , PA : WB Saunders; 1986; 360.
  • 74
    Ross L. Hypertension and chronic renal failure. Semin Vet Med Surg (Small Anim) 1992;7:221225.
  • 75
    Jacob F, Polzin DJ, Osborne CA, et al. Systemic hypertension in dogs with spontaneous chronic renal failure: Prevalence, target-organ damage, and survival. J Vet Intern Med 1999; 13: 253 (abstract).
  • 76
    Michell AR, Bodey AR, Cleadhill A. Absence of hypertension in dogs with renal insufficiency. Ren Fail 1997;19:6168.
  • 77
    Coulter D, Keith J. Blood pressures obtained by indirect measurements in conscious dogs. J Am Vet Med Assoc 1984;184:13751378.
  • 78
    Brown SA, Finco DR, Navar GN. Impaired renal autoregulatory ability in dogs with reduced renal mass. J Am Soc Nephrol 1995;5:17681774.
  • 79
    Bloom F Pathology of the Dog and Cat: The Genitourinary System with Clinical Considerations. Evanston , IL : American Veterinary Publications; 1954.
  • 80
    Grauer G, Greco DS, Getzy DM, et al. Effects of enalapril on dogs with glomerulo-nephropathy. J Vet Intern Med 1999; 13: 250 (abstract).
  • 81
    Grodecki KM, Gains MJ, Baumal R, et al. Treatment of X-linked hereditary nephritis in Samoyed dogs with angiotensin converting enzyme (ACE) inhibitor. J Comp Pathol 1997; 117:209225.
  • 82
    Verbeelen DL, De Craemer D, Peeters P, et al. Enalapril increases antioxidant enzyme activity in renal cortical tissue of five-sixths-nephrectomized rats. Nephron 1998;80:214219.
  • 83
    White JV, Finco DR, Crowell WA, et al. Effect of dietary protein on functional, morphologic, and histologic changes during compensatory renal growth in dogs. Am J Vet Res 1991;52:13571365.
  • 84
    Finco DR, Brown SA, Crowell WA, et al. Effects of dietary phosphorus and protein on dogs with chronic renal failure. Am J Vet Res 1992;53:22642271.
  • 85
    Finco DR, Brown SA, Cooper TA, et al. Effects of parathyroid hormone depletion in dogs with induced renal failure. Am J Vet Res 1994;55:867873.
  • 86
    Bovee KC, Kronfeld DS, Ramberg C, et al. Long-term measurement of renal function in partially nephrectomized dogs fed 56, 27, or 19% protein. Invest Urol 1979;16:378384.
  • 87
    Robertson JL, Goldschmidt MS, Kronfeld DS, et al. Long-term responses to high dietary protein intake in dogs with 75% nephrectomy. Kidney Int 1986;29:511519.
  • 88
    Polzin DJ, Leininger JR, Osborne CA, et al. Development of renal lesions in dogs after 11 /12 reduction in renal mass. Lab Invest 1988;58:172183.
  • 89
    Finco DR, Brown SA, Crowell WA, et al. Effects of aging and dietary protein intake on uninephrectomized geriatric dogs. Am J Vet Res 1994;55:12821290.